Our editors’ favorite portable generators give you reliable power whenever and wherever you need it

These editor-tested models are ideal for camping, tailgating, or powering tools when you’re too far from an outlet.
IEEE

A Single-phase AC Excitation Method with Phase-Shifting Capacitor for Aircraft Wound Rotor Synchronous Starter/Generator

Abstract: Wound rotor synchronous starter/generator (WRSSG) faces challenges in excitation during the starting mode. The existing single-phase AC excitation method, though simple to implement, suffers ...
eeworldonline

FAQ on three-phase AC power part 2: implementation

Q: How is the three-phase AC power generated? A: It does not use three separate generators that are somehow synchronized. Instead, it is relatively simple in principle: the generator is wound with ...
Forbes

AC/DC’s Biggest Single Is Soaring Across The Board

Forbes contributors publish independent expert analyses and insights. Hugh McIntyre covers music, with a focus on the global charts. AC/DC’s “Thunderstruck” climbs U.K. charts, hitting No. 5 on the ...
EurekAlert!

Capacitorless solid-state power filter for single-phase DC-AC converters

The consequences can be costly, ranging from production downtime to compromised equipment and even safety hazards. Certainly, capacitors are indeed responsible for 30% of power electronics failures, ...
EDN

Reference design trio covers EV chargers

Microchip has released three flexible and scalable EV charger reference designs for residential and commercial charging applications. These reference designs include a single-phase AC residential ...
ascopubs.org

A prospective, open-label, single-arm phase II clinical study of inetetamab in combination with pyrotinib and albumin-bound paclitaxel for the neoadjuvant treatment of patients ...

Trastuzumab, pertuzumab and nab-paclitaxel plus pyrotinib or not in neoadjuvant treatment of HER2-positive breast cancer: A multi-center, randomized, open-label, phase II study. This is an ASCO ...
ascopubs.org

Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA).

Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways with casdozokitug (casdozo, SRF388) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients ...